Mc Ilrath & Eck, LLC Abb Vie Inc. Transaction History

Mc Ilrath & Eck, LLC

$574 Million
Q3 2024

A detailed history of Mc Ilrath & Eck, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Mc Ilrath & Eck, LLC holds 826 shares of ABBV stock, worth $148,680. This represents 0.03% of its overall portfolio holdings.

Number of Shares

826

Previous 979 15.63%

Holding current value

$148,680

Previous $167,000 2.4%

% of portfolio

0.03%

Previous 0.03%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 19, 2024	SELL	$163.84 - $199.33 $25,067 - $30,497	-153 Reduced 15.63%	826 $163,000
Q2 2024 Aug 13, 2024	BUY	$154.79 - $180.76 $9,751 - $11,387	63 Added 6.88%	979 $167,000
Q3 2023 Nov 15, 2023	SELL	$133.59 - $154.65 $225,366 - $260,894	-1,687 Reduced 64.81%	916 $136,000
Q2 2023 Aug 07, 2023	SELL	$132.51 - $164.9 $29,284 - $36,442	-221 Reduced 7.83%	2,603 $350,000
Q1 2023 May 08, 2023	BUY	$144.61 - $166.54 $61,314 - $70,612	424 Added 17.67%	2,824 $450,000
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $111,339 - $133,525	-805 Reduced 25.12%	2,400 $388,000
Q3 2022 Oct 18, 2022	BUY	$134.21 - $153.93 $17,984 - $20,626	134 Added 4.36%	3,205 $430,000
Q2 2022 Jul 29, 2022	SELL	$137.62 - $174.96 $27,248 - $34,642	-198 Reduced 6.06%	3,071 $470,000
Q1 2022 May 11, 2022	BUY	$131.98 - $163.75 $16,101 - $19,977	122 Added 3.88%	3,269 $530,000
Q4 2021 Feb 08, 2022	SELL	$107.43 - $135.93 $49,095 - $62,120	-457 Reduced 12.68%	3,147 $426,000
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $83,736 - $95,053	787 Added 27.94%	3,604 $389,000
Q2 2021 Aug 09, 2021	SELL	$105.21 - $117.21 $36,928 - $41,140	-351 Reduced 11.08%	2,817 $317,000
Q1 2021 May 12, 2021	SELL	$102.3 - $112.62 $47,671 - $52,480	-466 Reduced 12.82%	3,168 $343,000
Q4 2020 Feb 05, 2021	BUY	$80.49 - $108.67 $45,154 - $60,963	561 Added 18.26%	3,634 $389,000
Q2 2020 Aug 04, 2020	BUY	$73.37 - $98.18 $52,973 - $70,885	722 Added 30.71%	3,073 $302,000
Q1 2020 May 14, 2020	SELL	$64.5 - $97.79 $24,574 - $37,257	-381 Reduced 13.95%	2,351 $179,000
Q4 2019 Feb 11, 2020	BUY	$72.13 - $90.25 $57,054 - $71,387	791 Added 40.75%	2,732 $242,000
Q3 2019 Nov 05, 2019	SELL	$62.98 - $75.72 $18,516 - $22,261	-294 Reduced 13.15%	1,941 $147,000
Q1 2019 May 07, 2019	SELL	$77.14 - $90.79 $5,168 - $6,082	-67 Reduced 2.91%	2,235 $180,000
Q4 2018 May 07, 2019	BUY	$77.85 - $96.01 $12,144 - $14,977	156 Added 7.27%	2,302 $212,000
Q3 2018 Nov 13, 2018	SELL	$88.91 - $98.84 $32,274 - $35,878	-363 Reduced 14.47%	2,146 $203,000
Q2 2018 Aug 07, 2018	BUY	$89.78 - $106.23 $13,467 - $15,934	150 Added 6.36%	2,509 $232,000
Q1 2018 May 22, 2018	SELL	$92.01 - $123.21 $132,126 - $176,929	-1,436 Reduced 37.84%	2,359 $223,000
Q4 2017 Mar 19, 2018	BUY	$89.56 - $98.21 $339,880 - $372,706	3,795	3,795 $367,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Ilrath & Eck, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mc Ilrath & Eck, LLC with notifications on news.

Account